Vertex Pharmaceuticals Investor

Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.

Connections from

Technology: Cancer
Industry: Biotechnology
Headquarters: United States
Founded Date: 1989
Employees Number: 1001-5000
Funding Status: IPO
Investor Type: Company
Investment Stage: N/A
Number Of Exits: 2
Acquisitions Number: 3
Investors Number: 9
Total Funding: 606197225
Estimated Revenue: $500M to $1B
Last Funding Date: 03 12 09
Last Funding Type: Post-IPO Equity

Visit Website
mediainfo@vrtx.com
http://twitter.com/VertexPharma
Register and Claim Ownership